Tammy Peterman
UMB FINANCIALAbout Tammy M. Peterman
Tamara (Tammy) M. Peterman, MS, RN, FAAN, is an independent director of UMB Financial Corporation (UMBF), age 67, serving on the board since 2019. She is President, Kansas City Division; Executive Vice President; Chief Operating Officer; and Chief Nursing Officer at The University of Kansas Health System, with deep expertise in operations, financial performance, regulatory and risk management, and specialized industry knowledge in healthcare .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| The University of Kansas Health System | EVP, COO, Chief Nursing Officer | Appointed July 2007 | Oversight of operations, financial performance, regulatory, and risk management |
| The University of Kansas Health System | President, Kansas City Division | Assumed July 2018 | Strategic operational oversight, guidance for nursing services, day-to-day operations across system locations |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| The University of Kansas Health System | President, Kansas City Division; EVP; COO; Chief Nursing Officer | 2007–present (President role since 2018) | Healthcare operations executive, FAAN credential |
Board Governance
- Independence: The Board determined Ms. Peterman is independent; UMB’s four standing committees are comprised solely of independent directors .
- Committees: Member, Governance Committee; Member, Risk Committee. Not listed as a member of Audit or Compensation Committees .
- Attendance: In 2024, the Board met 6 times; Audit met 5; Compensation 4; Governance 3; Risk 3. Each director attended at least 75% of meetings of the Board and committees on which they served; independent directors held three executive sessions chaired by the Lead Director .
- Shareholder engagement and governance documents: Committee charters and guidelines available via Investor Relations site .
Fixed Compensation
Director compensation framework and Ms. Peterman’s actual compensation:
| Item | 2023 | 2024 |
|---|---|---|
| Annual Cash Retainer (Policy) | $55,000 | $60,000 |
| Equity Retainer – Grant-Date Value (Policy) | $65,000 (non-Lead directors) | $80,000 |
| Committee Membership Retainers (Policy) | Governance: $6,500; Risk: $9,000 | Governance: $8,750; Risk: $10,000 |
| Committee Chair Retainers (Policy) | Governance: $13,000; Risk: $18,000 | Governance: $17,500; Risk: $20,000 |
| Peterman – Name | Fees Earned or Paid in Cash ($) | Stock Awards ($) | Total ($) |
|---|---|---|---|
| 2023 | 70,546 | 64,914 | 135,460 |
| 2024 | 78,814 | 64,954 | 143,768 |
- Equity grant timing: Annual director grants are typically made the first Friday following Q4 earnings; UMB does not currently grant stock options to directors .
- Note on reported stock award values: 2024 director stock award values reflect the equity retainer earned in 2023 and issued February 2, 2024 (ASC 718 grant-date fair value) .
Mix signal: For 2024, Peterman’s compensation consisted of $78,814 cash and $64,954 equity, reflecting both fixed cash retainer and fully vested stock; no meeting fees are paid .
Performance Compensation
| Component | Structure | Metrics/Conditions |
|---|---|---|
| Equity awards for directors | Fully vested stock at grant | No performance conditions; UMB does not currently grant stock options to directors |
| Meeting fees | Not applicable | No per-meeting fees paid to directors |
Other Directorships & Interlocks
| Category | Details |
|---|---|
| Current public company boards | None disclosed for Ms. Peterman |
| Prior public company boards | Not disclosed |
| Private/non-profit/academic boards | Executive leadership roles at The University of Kansas Health System; no other board roles disclosed |
| Interlocks/Conflicts | Compensation Committee interlocks: None for 2024; no director serving on Comp Committee was an officer/employee of UMB . No related-party transactions requiring disclosure among independent directors; ordinary-course banking relationships reviewed and deemed not impairing independence . |
Expertise & Qualifications
- MS, RN, FAAN; senior health system operator (President, KC Division; EVP; COO; CNO) with specialized healthcare industry knowledge .
- Experience overseeing operations, financial performance, regulatory compliance, and risk management—aligned to UMB’s board risk oversight and governance needs .
- Independent director since 2019; age 67, supporting board diversity and sector breadth .
Equity Ownership
| Holder | Shares Beneficially Owned | Percent of Class | As-of Date |
|---|---|---|---|
| Tamara M. Peterman | 8,321 | Less than 1% | Feb 28, 2025 |
- Ownership guidelines: Directors must hold UMB stock with market value ≥ 5x annual non-employee equity retainer; all directors are in compliance as of the proxy date .
- Hedging/derivatives: Prohibited under UMB’s Corporate Governance Guidelines; policy prohibits short sales, options, and hedging transactions .
Governance Assessment
- Board effectiveness: Peterman strengthens operational and risk oversight with healthcare regulatory experience; she serves on Governance and Risk Committees, both key to board composition, evaluation, shareholder engagement, and enterprise risk oversight .
- Independence and conflicts: The Board affirmed her independence; routine banking relationships of independent directors were reviewed and found on market terms with no relationships requiring Item 404(a) disclosure or impairing judgment .
- Attendance and engagement: The board/committee cadence and minimum attendance standard were met by all directors in 2024, supporting engagement; independent directors held three executive sessions, indicating active oversight .
- Pay and alignment: Director pay mix balances cash retainer with fully vested equity; equity grant timing is disciplined and options are not used for directors, reducing risk of misalignment; guidelines require substantial ongoing stock ownership and all directors are compliant, reinforcing alignment with shareholders .
- RED FLAGS: None disclosed specific to Peterman. Broader related-party transactions (e.g., billboard leases with a Kemper-related entity) are reviewed/approved by Audit Committee with market terms; not tied to Peterman .